Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$20.4 - $28.66 $194,820 - $273,703
-9,550 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$18.16 - $25.21 $173,428 - $240,755
9,550 New
9,550 $235,000
Q4 2020

Feb 16, 2021

SELL
$24.73 - $35.12 $436,286 - $619,587
-17,642 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$23.35 - $35.94 $411,940 - $634,053
17,642 New
17,642 $497,000

Others Institutions Holding RNA

About Avidity Biosciences, Inc.


  • Ticker RNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,127,000
  • Market Cap $2.12B
  • Description
  • Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...
More about RNA
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.